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Abstract As reviewed here, numerous biomechan-
ical and clinical studies support the use of controlled,
low temperature irradiation of allograft tendons, to
provide both excellent clinical results and medical-
device grade sterile allografts with minimal risk of
disease transmission.
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Introduction
The preferred method of terminal sterilization for
tendonallografts,gammairradiation,remainsaconcern
tosomesurgeons.Whilesomeolderstudieshaveshown
that higher, uncontrolled doses of gamma irradiation
([3 Mrad) can have detrimental effects on the strength
of allograft tissue, numerous studies suggest that the
currently used practices of low dose, controlled, low
temperature gamma irradiation are effective to achieve
terminal sterilization without detrimental impact on
allograft tissue strength. In this review, irradiation
methods are presented as well as biomechanical,
clinical, and safety assessments of irradiated tendons
used for ACL reconstructive procedures.
Irradiation methods
Prior to assessing studies regarding irradiated tendons,
it is important to understand how irradiation methods
are reported. Key variables of irradiation include:
• Target dose
• Dose range
• Temperature of irradiation
• Tissue treatment prior to irradiation
Target dose
The targeted dose is that (e.g., 22 kGy) which the
tissue is intended to be exposed. However, the manner
in which tissue is irradiated in its containeror chamber
does not allow all tissues to receive an exact similar
dose. If only a single targeted dose is reported for
tissue treatment, then that is likely the minimal
exposure dose. For example, an exposure reported as
25 kGy (2.5 Mrad) likely indicates that all materials
received at least 25 kGy exposure and that some may
have received a much higher dosage (e.g., the outer
grafts in a container). Thus, when only a single dose is
reported it is fair to consider that to represent the
minimal exposure and that some or most tissues will
receive a higher dose.
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The most accurate way to report an irradiation dose is
as a dose range, e.g. 15–18 kGy (1.5–1.8 Mrad),
which should indicate both the minimum and maxi-
mum dose exposure throughout the irradiated con-
tainer. In order to minimize any negative material
impact, it is important that both low doses and tightly
controlled dose ranges be employed. It is very difﬁcult
to interpret any study that does not include a dose
range.Again,ifonlyasingledoseisgiven,itshouldbe
considered the minimum exposure.
Temperature of irradiation
The third variable, temperature has been shown to be
important as low (dry ice) temperatures serve to
minimize any free radical generation and subsequent
tissue damage (Anderson et al. 1992; Hamer et al.
1999). Prior to knowledge of the importance of a
controlled irradiation dose range at low temperatures,
itisdifﬁculttorelyontheﬁndingsofstudieswherethe
details are not reported. Ideally a low average dose, at
a narrow dose range, and at low temperatures are all
factors in minimizing any irradiation-mediated alter-
ation of material properties.
Tissue treatment prior to irradiation
In addition, the treatment of any tendon prior to
irradiation could play a role in how the tissue is
potentially impacted. There are certain cleaning and
disinfection methods that involve harsh chemicals or
physicalforcesonthetissue.Thesemaydamagegrafts
independent of irradiation or pre-dispose grafts to
alteration by irradiation.
Summary
To best interpret study results involving irradiated
tissue, it is important to know how a tissue was treated
prior to irradiation and exactly how it was irradiated.
Biomechanical assessment of irradiated tendons
In testing biomechanical properties of irradiated
tendons, Balsly et al. (2008) reported no change in
graft strength or elastic modulus for bone-patellar
tendon-bone (BPTB) grafts, anterior tibialis tendons,
semitendinosustendons,orfascialatasofttissuegrafts
when treated with sterilizing, low dose (18.3–21.8
kGy) gamma irradiation at dry ice temperatures.
Likewise, Greaves et al. (2008) investigated the bio-
mechanical properties of low dose (14.6–18.0 kGy)
gamma irradiation on tibialis tendon allografts. In this
matched pair study, 63 tibialis tendons were irradiated
on dry ice while the contralateral tendons from the
same respective donors were not irradiated. The study
found that low dose irradiation did not signiﬁcantly
affect the failure load of either single stranded or
double stranded tibialis tendon grafts (Table 1).
In a similar study, Roche et al. (2005) investigated
the ultimate tensile strength of low dose gamma
irradiation (15.4–15.5 kGy) on patellar ligaments and
fascia lata allografts. Each irradiated allograft was
matched with a control non-irradiated graft from the
same donor to limit biomechanical variability result-
ing from different donors. The study did not ﬁnd a
statisticaldifferenceinthetensilestrengthbetweenthe
matched low dose irradiated and non-irradiated allo-
grafts. In addition, Gibbons et al. (1991) showed in a
biomechanical study that maximum stress, maximum
strain, and strain energy density to maximum stress
was not signiﬁcantly reduced in goat BPTB grafts
irradiated with 20 kGy of gamma irradiation. Further,
Goertzen et al. (1995) found no signiﬁcant difference
in strength between canine BPTB grafts irradiated
with 25 kGy and non-irradiated BTPB grafts after
being implanted in an ACL reconstruction for
Table 1 Failure load (N) of non-irradiated and irradiated
single-stranded and double-stranded tibialis tendon grafts as
reported by Greaves et al. (2008)
Irradiated Non-Irradiated
Group 1
Single stranded 3,062 ± 699 2,843 ± 694
Double stranded 5,124 ± 1,206 5,074 ± 1,032
Group 2
Single stranded 2,729 ± 995 2,823 ± 573
Double stranded 5,262 ± 845 5,255 ± 706
Group 3
Single stranded 3,004 ± 603 2,988 ± 787
Double stranded 5,334 ± 1,353 4,971 ± 1,980
No signiﬁcant differences were found with either treatment.
Groups 1, 2, and 3 refer to the donor age of that group (20–45,
46–55, 56–65 years respectively)
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12312 months. Finally, McGilvray et al. (2005) deter-
mined there was no signiﬁcant difference in the
stiffness, ultimate load, and ultimate strength of
porcine BPTB grafts treated with 15 kGy versus
non-irradiated porcine BPTB grafts. These and other
studies (Haut and Powlison 1990; Mae et al. 2003;
Maeda et al. 1993, 1998; Smith et al. 1996)o f
irradiated tendons indicate that treatment below
20–25 kGy have minimal impact on biomechanical
properties.
Clinical assessment of irradiated tendons
There is also clinical evidence supporting the utility of
low-dose irradiated tendons, which also have the
advantage of minimizing any risk of disease trans-
mission. Fanelli et al. (1996) compared irradiated
BPTB and Achilles tendon allografts versus BPTB
autografts for ACL reconstruction in patients who had
combined ACL/PCL instability. No irradiation levels
were given, so the presumption is of at least a
15–25 kGy dose. Although the sample size was low
(20 patients), the prospective study was the largest
study to date (1996) that evaluated ACL/PCL insta-
bility. This clinical study found equivalent results
between irradiated allografts and autograft tendons. In
a technique article, Harner and Elkousy, along with
lead author Sekiya et al. (2002), noted they only use
patellar tendon allografts that have been irradiated for
ACL reconstruction.
In further support, Rihn et al. (2006) investigated
the irradiation variable for ACL reconstruction in a
clinical study involving 102 patients with an average
follow-up of 4.2 years. The study found that 2.5 Mrad
of gamma irradiation on BPTB allografts, which is
effective ineliminating bacteria, does notcompromise
the clinical effectiveness of the grafts (Table 2). The
authors concluded ‘‘[t]hese data suggest that irradia-
tion can be used to sterilize BPTB allograft without
adversely affecting clinical outcome.’’
Taken together, the above articles suggest that a
sterilizing dose of irradiation may not be of clinically
signiﬁcant concern when using allografts for ACL
replacement. While three reports in particular have
presentedhigherfailureratesforirradiatedallograftsin
ACL reconstructions (Rappe et al. 2007; Sun et al.
2009; Prodromos et al. 2007), there are signiﬁcant
questions regarding these studies or data analysis.
Those study limitations are detailed here. The most
signiﬁcantissueswiththeﬁrststudy(Rappeetal.2007)
include questionable follow-up methodology and a
lack of information regarding the irradiation process
used. The study followed up with *73% of irradiated
graft patients compared with *93% of non-irradiated
graft patients. It is unclear why a substantially fewer
number of patients in the irradiated graft group
returned for follow up care especially since they
reportedlyhadsigniﬁcantgraftfailure(33%).Also,the
methodusedtoirradiatethegraftsisunknown,e.g.,the
temperature of irradiation. The irradiation dose is
given as 20–25 kGy and it is unknown if this is a true
dose range and what the dose range of irradiation
exposure actually was. In addition, other processing
methods are unknown, including whether these grafts
were also exposedtoharshsolventsorcyclicpressures
as performed by some banks, such that they may have
been prone to damage from the higher irradiation dose
used. Also, one surgeon reported twice the failure rate
astheotherinthestudyandtherecipientageinrelation
to failures in both groups was not reported, making
interpretation difﬁcult. Finally, many tissue providers
will routinely treat ‘non-irradiated’ or ‘non-sterilized’
grafts with 10–15 kGy doses of pre-processing irradi-
ationforsafetyreasonssoitremainsunknownwhether
the control grafts were truly non-irradiated and also
whether the irradiated grafts were double-dosed.
Table 2 ACL reconstruction results at average 4.2 years fol-
low-up from Rihn et al. (2006) study using either irradiated
BPTB allografts or BPTB autografts
Irradiated Allograft
reconstruction
(n = 39)
Autograft
reconstruction
(n = 63)
P value
IKDC
subjective
knee form
86.7 ± 15.5 88.0 ± 13.3 0.65
ADLS
a 93.4 ± 10.2 92.7 ± 10.5 0.72
SAS
b 90.1 ± 17.1 90.1 ± 12.8 0.99
Avg 30 lb.
KT-1000
c
1.1 ± 2.5 1.9 ± 2.3 0.11
Avg
maximum
manual
KT-1000
c
1.3 ± 2.3 2.2 ± 2.0 0.04
a Activites of daily living scale
b Sports activity scale
c Side-to-side difference of anterior translation in mm
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et al. study (2009). Only the target dosage is given
(25 kGy) with unknown dose range. Also, these grafts
were irradiated at room temperature and the grafts
were not disinfected prior to irradiation (author,
private communication). In addition, grafts were
soaked in iodine prior to use. These graft treatments
compromise any meaningful interpretation of the
results. As signiﬁcantly, the study has inconsistent
results that possibly indicate an issue in either the
surgery or measuring techniques. Unfortunately, the
allograft patients exhibited a signiﬁcant increase in
duration of post-operative fever over autograft
patients. The average duration of fever for an irradi-
ated allograft patient was over 1 week (8.8 days)
versus 4.7 days for the autograft patients. In the
discussion, the authors state that this high fever rate
‘‘was associated with…[different possibilities,
or]…the real ability of tissue banks in our country
[China] to process allografts’’. The study also con-
cludes that irradiated bone patellar-tendon bone
(BPTB) allografts are clinically inferior to both non-
irradiated BPTB allografts and BPTB autografts
because of the laxity measurements with a KT-2000
arthrometer. The study reports only 31.3% of irradi-
ated BPTB allografts had less than 3 mm of laxity
while 85.3% of the non-irradiated and 87.8% of the
autograft group had less than 3 mm of laxity. This is a
surprising difference made even larger by the report of
34.4% of the irradiated group exhibiting more than
5 mmoflaxity(deﬁnedasgraftfailurebytheauthors).
These extreme percentages should indicate notewor-
thy irradiated graft patient dissatisfaction as well as
signiﬁcantly different results in other subjective and
objective tests. In contrast, however, there were no
signiﬁcant differences in the overall IKDC scores
between any of the three groups. Irrgang et al. (1998)
noted that the IKDC was an especially rigorous
evaluation tool because the lowest score received in
any given area becomes the overall score instead of
combining the averages like other evaluation systems.
This makes the validity of the Sun et al. study even
more uncertain since laxity measurement is a compo-
nent of the overall IKDC score. It is unclear how there
was no signiﬁcant difference in the overall IKDC
score among the 3 groups when the irradiated graft
group had such extreme laxity measurements. Fur-
thermore, the objective range of motion (ROM),
vertical jump, and one-leg hop tests found no
signiﬁcant difference in any of the groups. There were
also no signiﬁcant differences among the 3 groups for
mean Lysholm, Tegner, or Cincinatti knee scores.
Moreover, there was not a signiﬁcant difference in
patients’ satisfaction with their ability to participate in
sports in any of the groups. One would expect
signiﬁcant differences in all or most of these tests
and responses if 68.7% of irradiated allograft patients
had greater than 3 mm laxity. The IKDC system isone
of the best evaluation tools to measure ACL recon-
struction results (Foster et al. 2010) and the results of
this test and all the others should have been balanced
against the arthrometer measurements. This balance is
particularly important because there may be no
correlation between laxity measurements and func-
tional outcome (Mirzayan 2005). Pollet et al. (2005)
investigated this correlation in a prospective, clinical
study of 29 ACL deﬁcient patients with an average
33 month followup. After comparing anterior knee
laxity, questionnaire based on IKDC score, sports
activity rating scale (SARS), activities of daily living
(ADL), and other tests, the study found ‘‘no correla-
tion between the joint laxity and the functional
outcome score.’’ This lack of correlation is actually
supported by the Sun et al. (2009) study in which,
according to the authors, almost 4 times as many
irradiated allograft patients had graft failure based on
laxity measurements but there was no statistical
difference in patients’ satisfaction in their postopera-
tive sports activity or overall IKDC score. At the very
least, the inconsistent results and non-standard tissue
treatment methods should have given the authors
pause before making the recommendation to com-
pletely discontinue use of irradiation to sterilize
allografts.
Prodromos et al. (2007) performed a meta-analysis
on stability of autografts and allografts for ACL
reconstruction. This included a sub-analysis of non-
irradiated vs. irradiated grafts. They came to the
following conclusion: ‘‘The direct deleterious effects
of graft radiation are an additional area of concern.
The stability rate in the radiation-sterilized grafts in
this studywas strikingly low.’’ However, the data used
to draw this conclusion is heavily skewed by one
particular study. In detail, to examine irradiated
tendons, the authors includedthree studies, here called
Noyes, Gorschewsky, and Rihn. They based conclu-
sions on normal stability rate (which was 43% for
irradiated vs. 63% for non-irradiated allograft) and
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and 12% for non-irradiated allografts). This certainly
appears negative for irradiated allografts. However,
the irradiated group included in the Gorschewsky
study included more grafts, and thus was more heavily
weighted, than the other two studies combined and,
most importantly, included a process method with
steps containing acetone, sodium hydroxide, and
hydrogen peroxide. These harsh chemicals can be
quite damaging to soft tissues and no conclusion can
be drawn from the fact that these grafts were also
irradiated unless the proper controls were included
(treatmentwiththesechemicalswithoutirradiation).If
this single study is removed from the meta-analysis,
thenthecomparisons become:normal stability ratesof
62% for irradiated vs. 63% for non-irradiated allo-
grafts and abnormal stability rates of 15% for irradi-
ated and 12% for non-irradiated allografts,
respectively. Thus, the exclusion of the harsh chem-
ically treated graft data set, yields results suggesting
equivalent performance for irradiated vs. non-irradi-
ated grafts. Further, note that this study that was, in
fact positive regarding irradiation reported on tissue
irradiated with 2.5 Mrad, which is even above com-
monly used levels of 13–18 kGy, further suggesting
the utility of terminal sterilization via gamma
irradiation.
Irradiated tissue safety
It appears that there still exists confusion as to the
deﬁnitions of sterility and processing methods. Sterile
or aseptic tissue recovery by itself is mistakenly
considered as a method that will result in the supply of
sterile grafts hence making terminal sterilization
unnecessary (Marrale et al. 2007). Recovery under
aseptic conditions seeks to ensure that no further
bioburden is introduced from the environment but
does not remove existing bioburden in the tissue
(Vangsness 2004; Vangsness et al. 2003). Tissue
banks must use disinfection steps and/or terminal
sterilization to accomplish sterilization of existing
bioburden. Furthermore, aseptic recovery occurring in
a surgical operating room can only result in, at best, a
sterility assurance level (SAL) of 10
-3, and then only
if properly validated, versus a terminal sterilization
SAL of 10
-6. Sterility assurance level gives the
probability of there being viable microorganisms on a
particular graft unit, instrument, etc. A SAL of 10
-6
indicates there is only at most a 1 out of 1,000,000
chance that a viable organism exists with any single
graft compared with an SAL of 10
-3 which indicates a
1 out of 1,000 chance (Vangsness et al. 2003). Some
tissue banks choose to use terminal sterilization to
increase the likelihood of the safety of their tissue. If
theallograftcanbeguaranteedtoaSALof10
-6thenit
may possibly possess an even lower degree of
infection risk than an autograft procedure (Bryans
et al. 2010; Katz et al. 2008).
While the potential risk of viral transmission is
extremely serious, it should be kept in perspective that
this risk is virtually non-existent if the allograft is
procured from a bank using intensive donor screening,
tissue disinfection procedures, and terminal steriliza-
tion methods that inactivate viruses. While some
studies reported that at least 30 kGy of gamma
irradiation is needed to inactivate HIV, these studies
have assumed HIV is present in high density levels
(Fideler et al. 1994; Hernigou et al. 2000). At least
30 kGy may be necessary to inactivate high density
amounts of HIV but is excessive for lower density
levels of the virus. If in the extremely unlikely event
that HIV is present at all, the donor screening and
tissue disinfection procedures help ensure that the
virus will only be present in extremely low density
amounts. The low 10–20 kGy dosage used for termi-
nal sterilization is able to deactivate 99.9% of any
remaining low-density HIV in allograft tissue (Moore
2010).
Discussion
The preferred method of terminal sterilization for
allografts, gamma irradiation, remains a concern to
some surgeons. However, while some studies have
shown high dose gamma irradiation ([3 Mrad) can
have detrimental effects on the strength of allograft
tissue, numerous studies have shown that the currently
used controlled and low doses of gamma irradiation
are effective in terminal sterilization and have no
detrimental effect on allograft tissue strength. Rihn
et al. (2006) determined that not only is using 25 kGy
of gamma irradiation on BPTB allografts effective in
preventing bacterial infection but it does not compro-
mise the clinical effectiveness of the graft. The results
are also comparable for soft tissue allografts. Balsly
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patellar tendons, anterior tibialis tendons, semitendi-
nosus tendons, and fascia lata soft tissue grafts when
low dose gamma irradiation was used to terminally
sterilize at low temperatures. Greaves et al. (2008)
found low dose gamma irradiation did not affect the
strength or stiffness of soft tissue tibialis tendon
allografts. The terminal gamma irradiation is neces-
sary in order to provide allograft tissue with a SAL of
10
-6 which is equivalent with implantable medical
devices. Low dose gamma irradiation (10–15 kGy) in
combination with donor screening and tissue process-
ing procedures allows for thorough bactericidal treat-
ment while maintaining intrinsic biomechanical
properties and ensuring successful clinical perfor-
mance (Block 2006).
Conclusions
As reviewed here, numerous biomechanical and
clinical studies support the use of controlled, low
temperatureirradiationofallografttendons,toprovide
both excellent clinical results and medical-device
grade sterile allografts with minimal risk of disease
transmission.
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